Acronym

CBER

V

Center for Biologics Evaluation and Research

A center within the U.S. Food and Drug Administration responsible for ensuring the safety purity and effectiveness of biological products. CBER regulates vaccines blood and blood products allergenic products tissue and cellular products gene therapies and other biologics conducting research reviewing applications and establishing standards for biological products used in medical treatment.

Support this acronym

Sponsor this acronym to increase visibility for your brand while supporting our community